Distributed Biomanufacturing: Rethinking Production and Logistics for Autologous Cell Therapies

Manufacturing and regulatory hurdles threaten cell and gene therapy progress

The article discusses how manufacturing and regulatory challenges are hindering the progress of cell and gene therapies, particularly in can

How excessive FDA manufacturing requirements are bottlenecking cell and gene therapy companies

The article argues that excessive FDA manufacturing requirements are crippling cell and gene therapy companies, using Grace Therapeutics as

Study Shows Low-Cost Portable Biotech Tools Can Expand Access to Research and Diagnostics in Resource-Limited Settings

A global research team led by University of Toronto's Leslie Dan Faculty of Pharmacy has demonstrated the effectiveness of low-cost, portabl

Next-generation immune models: bioinks, 3D bioprinting, and future directions

Molecular tumor boards show promise in bridging precision oncology's translation gap

This Perspective article examines the "translation gap" in precision oncology—the challenge of turning complex genomic data into actionable

China creates new regulatory pathway to accelerate access to advanced biomedical therapies

China has established a new regulatory "tech track" for advanced therapies like personalized cancer treatments, cell and gene therapies, and